<DOC>
	<DOC>NCT03042273</DOC>
	<brief_summary>This clinical trial is a Phase 2, multicenter, placebo-controlled, double-blind, parallel-arm study to evaluate the efficacy and safety of High Strength Cranberry (500mg Pacran®) in preventing UTI (cystitis) in women with a history of recurrent UTI (rUTI).</brief_summary>
	<brief_title>High Strength Cranberry Supplementation for Prevention of Recurrent Urinary Tract Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<criteria>1. Females aged 1865 years, inclusive 2. A history of recurrent urinary tract infection defined as ≥3 UTIs in the last year OR at least 2 UTIs occurring in the last 6 months. Each infection requires confirmation by a health professional and at least one infection confirmed by culture. 3. Willing to answer questionnaires and comply with the study requirements 4. Ability to swallow capsules 5. Provided Written Informed Consent 1. Microbial growth on urine culture of ≥107 cfu/L (104cfu/mL) within 7 days of Day 1 2. A history of &gt;5 UTIs in the last 6 months (confirmed by selfreport or health professional) 3. Use of antibiotics or antibiotics for prophylaxis within 28 days of Day 1 4. Use of any antibacterial products, that in the opinion of the Medical Investigator may interfere with the study outcomes, within 28 days of Day 1 5. Regular use of Vaccinium containing products (e.g. all forms of blueberries, cranberries, bilberry, lingonberry , etc i.e fruit, dried fruit, pills, juices or supplements) within 28 days of Day 1 at the discretion of the Medical Investigator 6. Presence of an intermittent or indwelling urinary catheter 7. Anatomical abnormalities of the urinary tract</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>recurrent</keyword>
</DOC>